Source: Contract Pharma

RoosterBio: Univercells, RoosterBio Partner to Optimize Manufacturing of Extracellular Vesicles

Aim to leverage scalable, continuous bioprocessing technologies to deliver regenerative therapies at reduced timelines and costs.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Timothy M Kelly's photo - CEO of RoosterBio

CEO

Timothy M Kelly

CEO Approval Rating

84/100

Read more